RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +10.8% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 7.11M | -4.2% | $23.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passive) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passive) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passive) | 6.89M | +12.6% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 4.19M | — | $13.67M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 3.65M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Millennium Management ✦ | 3.57M | +52.0% | $11.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 2.19M | +120.6% | $7.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 2.19M | +120.6% | $7.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Geode Capital Management ✦ (passive) | 1.91M | -5.7% | $6.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Geode Capital Management ✦ (passive) | 1.91M | -5.7% | $6.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 42 | State Street Global Advisors ✦ (passive) | 1.75M | -10.2% | $5.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 1.67M | +970.8% | $5.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | Two Sigma Investments ✦ | 1.61M | -6.7% | $5.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 1.27M | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 1.27M | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 1.06M | -3.5% | $3.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 1.06M | -3.5% | $3.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 873.25K | +12.3% | $2.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 311.70K | +17.2% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 311.70K | +17.2% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 56 | Renaissance Technologies ✦ | 137.18K | -70.3% | $447,197 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 195 holders, 96.37M shares, $341.40M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.29K sh · $7,753
Officer · 631 sh · $2,133
Officer · 4.70K sh · $16,449
Officer · 36.66K sh · $128,266
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology